A new biologically active malyngamide from a New Zealand collection of the sea hare Bursatella leachii

J Nat Prod. 2002 Apr;65(4):630-1. doi: 10.1021/np010511e.

Abstract

A new malyngamide, S (1), was isolated from a New Zealand collection of the sea hare Bursatella leachii and structurally characterized by spectroscopic methods and chemical degradation. Malyngamide S exhibited cytotoxicity and antiinflammatory properties.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Anti-Inflammatory Agents / chemistry
  • Anti-Inflammatory Agents / isolation & purification*
  • Anti-Inflammatory Agents / pharmacology
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / isolation & purification*
  • Antineoplastic Agents / pharmacology
  • Bacillus subtilis / drug effects
  • Chromatography, High Pressure Liquid
  • Cyclohexanones / chemistry
  • Cyclohexanones / isolation & purification*
  • Cyclohexanones / pharmacology
  • Drug Screening Assays, Antitumor
  • Escherichia coli / drug effects
  • Fatty Acids, Monounsaturated / chemistry
  • Fatty Acids, Monounsaturated / isolation & purification*
  • Fatty Acids, Monounsaturated / pharmacology
  • HL-60 Cells
  • Humans
  • Leukemia P388
  • Mice
  • Molecular Structure
  • Mollusca / chemistry*
  • Mycobacterium tuberculosis / drug effects
  • New Zealand
  • Nuclear Magnetic Resonance, Biomolecular
  • Tumor Cells, Cultured / drug effects

Substances

  • 7S-methoxydodec-4E-enoic acid
  • Anti-Inflammatory Agents
  • Antineoplastic Agents
  • Cyclohexanones
  • Fatty Acids, Monounsaturated
  • malyngamide S